The emerging treatment of this peptide represents a significant development in the handling of the condition. Different to existing drugs, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and GIP https://tirzepatide-peptide741223.blogars.com/40498278/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment